Efficacy of 12-weeks velpatasvir plus sofosbuvir-based regimen in HCV-naive subjects with mild fibrosis: a meta-analysis

BACKGROUND AND AIMS: In literature systematic data on treatment with the fixed-dose combination of sofosbuvir and velpatasvir for 12 weeks in anti-HCV/HCV RNA positive subjects with mild fibrosis and naïve to previous Interferon free regimen are scanty. A meta-analysis has been performed to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Mariantonietta, Pisaturo, Antonio, Russo, Lorenzo, Onorato, Nicola, Coppola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776220/
https://www.ncbi.nlm.nih.gov/pubmed/31124995
http://dx.doi.org/10.23750/abm.v90i2.8374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776220/
https://www.ncbi.nlm.nih.gov/pubmed/31124995
http://dx.doi.org/10.23750/abm.v90i2.8374

Ejemplares similares